scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.19.2.266 |
P698 | PubMed publication ID | 9974406 |
P2093 | author name string | Farnier M | |
Athias A | |||
Desrumaux C | |||
Gambert P | |||
Lagrost L | |||
Bessède G | |||
Vergès B | |||
Perségol L | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hyperlipidemia | Q1079120 |
preproinsulin | Q7240673 | ||
P304 | page(s) | 266-275 | |
P577 | publication date | 1999-02-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIa hyperlipidemic, type IIb hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA. | |
P478 | volume | 19 |
Q31575347 | A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins |
Q45041067 | Active and low-active forms of serum phospholipid transfer protein in a normal Finnish population sample |
Q35592465 | Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins |
Q43992172 | Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity |
Q44445906 | Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy |
Q37119309 | Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: consequences for atherosclerosis development |
Q47328678 | Early decreases in plasma lipid transfer proteins during weight reduction |
Q33338480 | Elevated expression of phospholipid transfer protein in bone marrow derived cells causes atherosclerosis |
Q46865630 | Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus |
Q44195493 | Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion |
Q34657972 | Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology |
Q34114968 | Isolation and partial characterization of the inactive and active forms of human plasma phospholipid transfer protein (PLTP). |
Q33673882 | LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size |
Q36343495 | New insight into the pathophysiology of lipid abnormalities in type 2 diabetes |
Q44499489 | PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity |
Q35350326 | Pathophysiology of diabetic dyslipidaemia: where are we? |
Q52346293 | PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity. |
Q44287744 | Phospholipid and cholesteryl ester transfer are increased in lipoprotein lipase deficiency |
Q44053804 | Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. |
Q51505156 | Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus. |
Q37469242 | Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor |
Q44380415 | Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus |
Q43744167 | Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin |
Q44457158 | Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men. |
Q74106105 | Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity |
Q79294210 | Quantitation of the active and low-active forms of human plasma phospholipid transfer protein by ELISA |
Q33780365 | Recombinant human plasma phospholipid transfer protein (PLTP) to prevent bacterial growth and to treat sepsis. |
Q33996892 | Reverse cholesterol transport in diabetes mellitus |
Q35341853 | Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism |
Q37100511 | Serum CETP and PLTP activity in middle-aged men living in urban or rural area of the Lower Silesia region. PURE Poland sub-study. |
Q51741207 | Serum cholesteryl ester transfer protein concentrations are associated with serum levels of total cholesterol, beta-lipoprotein and apoproteins in patients with type 2 diabetes mellitus. |
Q43182286 | Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes |
Q73644431 | Study of vitamin E net mass transfer between alpha-tocopherol-enriched HDL and erythrocytes: application to asymptomatic hypercholesterolemic men |
Q34187337 | The impact of phospholipid transfer protein (PLTP) on HDL metabolism |
Q44955621 | Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations |
Search more.